Norges Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-197,716
| Closed | -$1.86M | – | 2203 |
|
|
2020
Q3 | $1.86M | Hold |
197,716
| – | – | ﹤0.01% | 1974 |
|
|
2020
Q2 | $1.51M | Hold |
197,716
| – | – | ﹤0.01% | 1989 |
|
|
2020
Q1 | $1.22M | Hold |
197,716
| – | – | ﹤0.01% | 1963 |
|
|
2019
Q4 | $2.41M | Hold |
197,716
| – | – | ﹤0.01% | 1969 |
|
|
2019
Q3 | $2.28M | Hold |
197,716
| – | – | ﹤0.01% | 1983 |
|
|
2019
Q2 | $1.98M | Sell |
197,716
-95,482
| -33% | -$1.03M | ﹤0.01% | 2003 |
|
|
2019
Q1 | $3.78M | Hold |
293,198
| – | – | ﹤0.01% | 1967 |
|
|
2018
Q4 | $4.45M | Hold |
293,198
| – | – | ﹤0.01% | 1937 |
|
|
2018
Q3 | $5.86M | Hold |
293,198
| – | – | ﹤0.01% | 1946 |
|
|
2018
Q2 | $5.72M | Hold |
293,198
| – | – | ﹤0.01% | 1927 |
|
|
2018
Q1 | $5.91M | Sell |
293,198
-446,468
| -60% | -$7.55M | ﹤0.01% | 1871 |
|
|
2017
Q4 | $9.8M | Hold |
739,666
| – | – | ﹤0.01% | 1745 |
|
|
2017
Q3 | $13.6M | Hold |
739,666
| – | – | 0.01% | 1634 |
|
|
2017
Q2 | $13.6M | Buy |
739,666
+117,600
| +19% | +$2.33M | 0.01% | 1628 |
|
|
2017
Q1 | $14M | Buy |
622,066
+49,827
| +9% | +$1.19M | 0.01% | 1594 |
|
|
2016
Q4 | $19.9M | Buy |
572,239
+195,133
| +52% | +$5.83M | 0.01% | 1307 |
|
|
2016
Q3 | $8.83M | Buy |
377,106
+59,539
| +19% | +$1.49M | ﹤0.01% | 1712 |
|
|
2016
Q2 | $7.6M | Hold |
317,567
| – | – | ﹤0.01% | 1740 |
|
|
2016
Q1 | $7.43M | Hold |
317,567
| – | – | ﹤0.01% | 1701 |
|
|
2015
Q4 | $9.59M | Hold |
317,567
| – | – | ﹤0.01% | 1610 |
|
|
2015
Q3 | $12.6M | Buy |
317,567
+287,567
| +959% | +$17.8M | 0.01% | 1423 |
|
|
2015
Q2 | $2.07M | Buy |
30,000
+10,000
| +50% | +$629K | ﹤0.01% | 2034 |
|
|
2015
Q1 | $1.09M | Buy |
+20,000
| New | +$953K | ﹤0.01% | 2149 |
|
|
2014
Q4 | – | Sell |
-76,824
| Closed | -$2.45M | – | 2376 |
|
|
2014
Q3 | $2.45M | Sell |
76,824
-297,912
| -79% | -$6.35M | ﹤0.01% | 2064 |
|
|
2014
Q2 | $7.76M | Buy |
374,736
+187,368
| +100% | +$3.46M | ﹤0.01% | 2002 |
|
|
2014
Q1 | $3.63M | Hold |
187,368
| – | – | ﹤0.01% | 1957 |
|
|
2013
Q4 | $4.55M | Hold |
187,368
| – | – | ﹤0.01% | 1924 |
|
|
2013
Q3 | $4.02M | Buy |
187,368
+3,200
| +2% | +$75.6K | ﹤0.01% | 1957 |
|
|
2013
Q2 | $4.1M | Buy |
+184,168
| New | +$4.06M | ﹤0.01% | 1922 |
|
Norges Bank's AMAG Position: Q4 2020 in Review
Norges Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 197,716 shares — an estimated $1.86M sold.
Norges Bank first reported a position in AMAG in Q2 2013 and held it in 29 quarters. The position peaked at $19.9M in Q4 2016. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Norges Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Norges Bank sold 197,716 AMAG Pharmaceuticals shares in Q4 2020, an estimated $1.86M.
- Norges Bank first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 29 quarters.
- Norges Bank's AMAG Pharmaceuticals position peaked at $19.9M in Q4 2016.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.